Products   |   CPSIA Certifications
 
CPSIA Certifications

Consumer Product Safety Improvement Act (CPSIA) Certifications

The Consumer Product Safety Improvement Act of 2008 (CPSIA) requires manufacturers to provide additional information on the child-resistant packaging of certain pharmaceuticals sold in the United States. More information about the details of this new law and its implementation may be found on the .

The following is a list of prescription products that are distributed by Harris Pharmaceutical, Inc. which are subject to the provisions of CPSIA. In accordance with requirements for assuring that each product listed below complies with the Child-Resistance Packaging requirements, the design of the packaging was tested as indicated in each product certificate of compliance.

NDC# (67405 -) Product Name Product Strength Package Size PDF
575-10 HydrOXYzine HCl Tablets 10 mg 100 PDF LINK
575-50 HydrOXYzine HCl Tablets 10 mg 500 PDF LINK
575-96 HydrOXYzine HCl Tablets 10 mg 1000 PDF LINK
671-10 HydrOXYzine HCl Tablets 25 mg 100 PDF LINK
671-50 HydrOXYzine HCl Tablets 25 mg 500 PDF LINK
671-96 HydrOXYzine HCl Tablets 25 mg 1000 PDF LINK
577-10 HydrOXYzine HCl Tablets 50 mg 100 PDF LINK
577-50 HydrOXYzine HCl Tablets 50 mg 500 PDF LINK
543-03 Terbinafine HCl Tablets 250mg 30 PDF LINK
543-10 Terbinafine HCl Tablets 250mg 100 PDF LINK

If you are unable to find a certificate of conformity for one of our products on this website, please contact Harris at (239)278-4749 or .